TR201905548T4 - Kanser kök hücresi hedefli ve ilaç dirençli kanser terapisi. - Google Patents
Kanser kök hücresi hedefli ve ilaç dirençli kanser terapisi. Download PDFInfo
- Publication number
- TR201905548T4 TR201905548T4 TR2019/05548T TR201905548T TR201905548T4 TR 201905548 T4 TR201905548 T4 TR 201905548T4 TR 2019/05548 T TR2019/05548 T TR 2019/05548T TR 201905548 T TR201905548 T TR 201905548T TR 201905548 T4 TR201905548 T4 TR 201905548T4
- Authority
- TR
- Turkey
- Prior art keywords
- drug resistant
- stem cell
- cell targeted
- cancer
- cancer stem
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 3
- 201000011510 cancer Diseases 0.000 title abstract 3
- 239000003814 drug Substances 0.000 title abstract 2
- 229940079593 drug Drugs 0.000 title abstract 2
- 208000016691 refractory malignant neoplasm Diseases 0.000 title abstract 2
- 210000000130 stem cell Anatomy 0.000 title abstract 2
- 238000011275 oncology therapy Methods 0.000 title 1
- 210000004027 cell Anatomy 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- PTLRDCMBXHILCL-UHFFFAOYSA-M sodium arsenite Chemical compound [Na+].[O-][As]=O PTLRDCMBXHILCL-UHFFFAOYSA-M 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/36—Arsenic; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Oncology (AREA)
- Physiology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Mevcut buluş kanser hücrelerini tedavi etmek, azaltmak ya da elimine etmek için farmasötik kompozisyonlar sağlamaktadır; daha özel olarak mevcut buluş kanser kök hücreleri ve ilaç dirençli kanser hücrelerinin azaltılması ya da elimine edilmesi için sodyum meta arsenit rejiminin terapötik olarak etkili bir miktarını sağlamaktadır.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24118009P | 2009-09-10 | 2009-09-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
TR201905548T4 true TR201905548T4 (tr) | 2019-05-21 |
Family
ID=43647965
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2019/05548T TR201905548T4 (tr) | 2009-09-10 | 2010-09-09 | Kanser kök hücresi hedefli ve ilaç dirençli kanser terapisi. |
Country Status (24)
Country | Link |
---|---|
US (1) | US20110059186A1 (tr) |
EP (1) | EP2475362B1 (tr) |
JP (1) | JP5710619B2 (tr) |
KR (2) | KR101721009B1 (tr) |
CN (2) | CN107412771A (tr) |
AR (1) | AR079000A1 (tr) |
AU (1) | AU2010292192B2 (tr) |
BR (1) | BR112012008315B1 (tr) |
CA (1) | CA2772411C (tr) |
CY (1) | CY1121973T1 (tr) |
DK (1) | DK2475362T3 (tr) |
ES (1) | ES2723778T3 (tr) |
HU (1) | HUE043387T2 (tr) |
IN (1) | IN2012DN02008A (tr) |
LT (1) | LT2475362T (tr) |
MX (1) | MX2012002855A (tr) |
PL (1) | PL2475362T3 (tr) |
PT (1) | PT2475362T (tr) |
RU (1) | RU2568834C2 (tr) |
SG (2) | SG179069A1 (tr) |
SI (1) | SI2475362T1 (tr) |
TR (1) | TR201905548T4 (tr) |
TW (1) | TWI564012B (tr) |
WO (1) | WO2011031890A2 (tr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1721615A1 (en) | 2005-05-09 | 2006-11-15 | Komipharm International Co., Ltd. | Pharmaceutical compositions comprising sodium or potassium arsenite for the treatment of urogenital cancer and its metastasis |
US20120251628A1 (en) * | 2011-03-30 | 2012-10-04 | Young Joo Min | Compositions and methods for treatment of cancer |
KR101701235B1 (ko) | 2013-09-30 | 2017-02-03 | 한국원자력의학원 | Hrp-3 억제제를 포함하는 방사선 또는 약물내성 암의 치료용 약학 조성물 |
WO2017165675A1 (en) * | 2016-03-24 | 2017-09-28 | The Board Of Regents Of The University Of Texas System | Treatment of drug resistant proliferative diseases with telomerase mediated telomere altering compounds |
JP2020521743A (ja) | 2017-05-24 | 2020-07-27 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 癌を処置するためのアンチセンス療法 |
TWI749414B (zh) * | 2019-11-29 | 2021-12-11 | 高雄醫學大學 | 細胞學抹片影像自動分析及診察結果自動批改方法 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5441050A (en) | 1992-12-18 | 1995-08-15 | Neoprobe Corporation | Radiation responsive surgical instrument |
CA2183547C (en) * | 1994-02-18 | 2002-05-14 | Tamara Vasilievna Vorobieva | Compositions for treating defective cell functions |
US5362735A (en) * | 1994-02-23 | 1994-11-08 | Smithkline Beecham Corporation | Rapamycin derivatives |
EP1621077B1 (en) * | 1997-10-15 | 2008-09-24 | Polarx Biopharmaceuticals, Inc. | Phamaceutical compositions comprising arsenic trioxide for the treatment of a tumor of the central nervous system |
ID25622A (id) * | 1997-11-10 | 2000-10-19 | Sloan Kettering Inst Cancer | Proses untuk memproduksi formulasi arsenat trioksida dan metoda untuk mengobati kanker dengan menggunakan arsenat trioksida atau melarsoprol |
CN1233476A (zh) * | 1998-04-24 | 1999-11-03 | 陆道培 | 治疗急性白血病的药物及其制备方法 |
US6262070B1 (en) * | 1998-11-04 | 2001-07-17 | Darwin Discovery Ltd. | Heterocyclic compounds and their therapeutic use |
TW200408407A (en) * | 2001-11-30 | 2004-06-01 | Dana Farber Cancer Inst Inc | Methods and compositions for modulating the immune system and uses thereof |
DK2042182T3 (da) * | 2002-04-10 | 2013-08-26 | Komipharm Int Co Ltd | Farmaceutisk sammensætning, der omfatter arsen, til behandling af malignitet. |
WO2006104292A1 (en) * | 2005-03-31 | 2006-10-05 | Komipharm International Co., Ltd. | Pharmaceutical composition comprising arsenic acid, meta-arsenite, and pharmaceutically acceptable salts |
EP1721615A1 (en) * | 2005-05-09 | 2006-11-15 | Komipharm International Co., Ltd. | Pharmaceutical compositions comprising sodium or potassium arsenite for the treatment of urogenital cancer and its metastasis |
US20060292243A1 (en) * | 2005-06-24 | 2006-12-28 | Shao-Chi Hsin | Arsenic compounds for the treatment of the arsenic-sensitive blast-cell related diseases |
US8945505B2 (en) * | 2007-02-02 | 2015-02-03 | Panaphix, Inc. | Use of arsenic compounds for treatment of pain and inflammation |
US20080279961A1 (en) * | 2007-05-11 | 2008-11-13 | Burger Angelika M | Telomere targeting agents as stem cells directed treatments |
US20090246291A1 (en) * | 2008-03-27 | 2009-10-01 | Angelika Burger | Method and compositions for treatment of cancer |
CN102753188A (zh) * | 2009-09-18 | 2012-10-24 | 柯密纳克斯公司 | 治疗脑瘤的方法 |
-
2010
- 2010-09-09 CA CA2772411A patent/CA2772411C/en active Active
- 2010-09-09 SG SG2012016747A patent/SG179069A1/en unknown
- 2010-09-09 JP JP2012528903A patent/JP5710619B2/ja active Active
- 2010-09-09 KR KR1020157007013A patent/KR101721009B1/ko active IP Right Grant
- 2010-09-09 ES ES10816100T patent/ES2723778T3/es active Active
- 2010-09-09 SG SG10201608967WA patent/SG10201608967WA/en unknown
- 2010-09-09 DK DK10816100.1T patent/DK2475362T3/da active
- 2010-09-09 LT LTEP10816100.1T patent/LT2475362T/lt unknown
- 2010-09-09 SI SI201031884T patent/SI2475362T1/sl unknown
- 2010-09-09 RU RU2012108144/15A patent/RU2568834C2/ru active
- 2010-09-09 CN CN201610829065.6A patent/CN107412771A/zh active Pending
- 2010-09-09 PT PT10816100T patent/PT2475362T/pt unknown
- 2010-09-09 BR BR112012008315-5A patent/BR112012008315B1/pt active IP Right Grant
- 2010-09-09 EP EP10816100.1A patent/EP2475362B1/en active Active
- 2010-09-09 TR TR2019/05548T patent/TR201905548T4/tr unknown
- 2010-09-09 CN CN201080040472XA patent/CN102753164A/zh active Pending
- 2010-09-09 HU HUE10816100A patent/HUE043387T2/hu unknown
- 2010-09-09 MX MX2012002855A patent/MX2012002855A/es active IP Right Grant
- 2010-09-09 WO PCT/US2010/048308 patent/WO2011031890A2/en active Application Filing
- 2010-09-09 AU AU2010292192A patent/AU2010292192B2/en active Active
- 2010-09-09 PL PL10816100T patent/PL2475362T3/pl unknown
- 2010-09-09 KR KR1020127007326A patent/KR20120061908A/ko active Application Filing
- 2010-09-10 US US12/879,347 patent/US20110059186A1/en not_active Abandoned
- 2010-09-10 AR ARP100103325A patent/AR079000A1/es not_active Application Discontinuation
- 2010-09-10 TW TW099130698A patent/TWI564012B/zh active
-
2012
- 2012-03-06 IN IN2008DEN2012 patent/IN2012DN02008A/en unknown
-
2019
- 2019-04-23 CY CY20191100443T patent/CY1121973T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12020550450A1 (en) | Certain chemical entities, compositions and methods | |
IN2012DN02805A (tr) | ||
PH12015502362A1 (en) | Certain chemical entities, compositions and methods | |
UA118248C2 (uk) | Інгібітори глюкозилцерамідсинтази | |
EP2493464A4 (en) | METHYLSULFONYLMETHANE (MSM) FOR THE TREATMENT OF DRUG-RESISTANT MICROORGANISMS | |
EA201300860A1 (ru) | Кристаллические трипептидные ингибиторы эпоксикетон-протеазы | |
MX345928B (es) | Composiciones terapeuticamente activas y metodos de uso de las mismas. | |
NZ706296A (en) | Glucosylceramide synthase inhibitors | |
TR201905548T4 (tr) | Kanser kök hücresi hedefli ve ilaç dirençli kanser terapisi. | |
GB201118656D0 (en) | New compounds | |
GEP20156229B (en) | 5-alkynyl-pyrimidines | |
IN2012DN01961A (tr) | ||
MX2016003486A (es) | Inhibidores de glucosilceramida sintasa para el tratamiento de enfermedades. | |
MX2011011854A (es) | Dihidropirimidinonas para uso como inhibidores de la bace2. | |
MX2012000709A (es) | Inhibidores de pirrolopiridina de cinasas. | |
IN2012DN02471A (tr) | ||
UA107204C2 (uk) | Протигрибкова композиція, що містить грибковий організм pythium oligandrum | |
GEP201606514B (en) | Apoptosis inhibitors and usage thereof | |
PH12016500136A1 (en) | Positive allosteric modulators of nicotinic acetylcholine receptor | |
BR112012015677A2 (pt) | Compostos farmacêuticos. | |
MX2011008994A (es) | Metodos de usar sns - 595 para el tratamiento de sujetos con cancer con actividad reducida de brca2. | |
EA201171414A1 (ru) | Ингибиторы белков семейства iap | |
TR200900879A2 (tr) | Aktif maddelerin tek bir dozaj formunda kombine edildiği farmasötik bileşimler | |
MD20140001A2 (ro) | Modulatori alosterici pozitivi ai receptorului nicotinic al acetilcolinei | |
MX2012001797A (es) | Inhibidores de catepsina c. |